4D Molecular Therapeutics Inc Financial Flexibility Index
4D Molecular Therapeutics Inc financial flexibility index. 4D Molecular Therapeutics Inc (FDMT) has a Financial Flexibility Index of 0.48x as of December 2025. Free cash flow of $29.18 Million (operating CF $28.55 Million minus capex $631.00K) represents 0% of total liabilities ($61.05 Million). See 4D Molecular Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of 4D Molecular Therapeutics Inc (2017–2025)
Financial flexibility index of 4D Molecular Therapeutics Inc from 2017 to 2025. Historical Financial Flexibility Index trend for 4D Molecular Therapeutics Inc across 9 annual periods. Check FDMT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
4D Molecular Therapeutics Inc Financial Flexibility Index by Year (2017–2025)
4D Molecular Therapeutics Inc financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for 4D Molecular Therapeutics Inc. For the full cash flow conversion analysis, see 4D Molecular Therapeutics Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.78x | $-108.55 Million | $-109.08 Million | $61.05 Million | ▲ +32.3% |
| 2024 | -2.63x | $-130.80 Million | $-134.59 Million | $49.78 Million | ▼ -15.4% |
| 2023 | -2.28x | $-73.02 Million | $-75.79 Million | $32.06 Million | ▲ +7.5% |
| 2022 | -2.46x | $-75.15 Million | $-86.69 Million | $30.51 Million | ▼ -41.1% |
| 2021 | -1.75x | $-60.02 Million | $-69.13 Million | $34.38 Million | ▼ -11.7% |
| 2020 | -1.56x | $-49.91 Million | $-50.91 Million | $31.94 Million | ▼ -511.8% |
| 2019 | -0.26x | $-33.51 Million | $-36.71 Million | $131.20 Million | ▼ -100.8% |
| 2018 | -0.13x | $-15.84 Million | $-16.25 Million | $124.56 Million | ▼ -167.7% |
| 2017 | 0.19x | $8.81 Million | $8.24 Million | $46.91 Million | — |